Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Oncology Treatment Tourism Market Revenue Growth On Track For A 10.6% CAGR Through 2030
The oncology treatment tourism market has experienced rapid expansion in recent years. It is projected to increase from $6.99 billion in 2025 to $7.71 billion in 2026, at a compound annual growth rate (CAGR) of 10.4%. The historic growth of this market can be attributed to factors including the rising global prevalence of cancer, the high expenses of oncology treatment in developed nations, restricted access to advanced therapies within home countries, the development of medical tourism infrastructure, and increasing awareness of international treatment options.
The oncology treatment tourism market size is anticipated to undergo rapid expansion over the next few years. It is projected to increase to $11.54 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 10.6%. This growth during the forecast period is fueled by the increased embrace of personalized oncology therapies, the broadening of international insurance coverage for cross-border medical services, rising investment in specialized cancer treatment centers, a surging demand for shorter treatment waiting periods, and greater cooperation among healthcare providers globally. Significant trends expected in the forecast period encompass enhanced cross-border accessibility to advanced cancer therapies, a growing need for cost-effective oncology treatments, the proliferation of international cancer centers of excellence, an increase in partnerships between hospitals and medical tourism agencies, and a rising preference for comprehensive treatment and hospitality packages.
Get A Free Sample Report With In-Depth Market Insights:
Oncology Treatment Tourism Market Development Factors: What’s Supporting Demand?
The expanding occurrence of cancer is projected to stimulate the expansion of the oncology treatment tourism market in the future. Cancer refers to a collection of illnesses marked by the unregulated proliferation and dissemination of atypical cells within the body, capable of invading adjacent tissues and spreading to remote organs. The escalation in cancer cases stems from aging demographics, given that older individuals face an elevated likelihood of acquiring genetic mutations that may result in cancer. Oncology treatment tourism assists cancer patients by facilitating access to sophisticated therapies, expert oncologists, and novel treatment approaches that might not be easily accessible in their native countries. It contributes to lowering treatment expenses and wait times, concurrently providing extensive care packages, thereby enhancing accessibility, ensuring continuity of care, and boosting overall treatment outcomes. For example, in February 2024, the World Health Organization, an international organization based in Switzerland, projected that more than 35 million new cancer cases are anticipated by 2050, representing a 77% increase from the 20 million cases recorded in 2022. Consequently, the rising occurrence of cancer is fueling the expansion of the oncology treatment tourism market.
Oncology Treatment Tourism Market Segment Analysis: What Are The Core Market Categories?
The oncology treatment tourism market covered in this report is segmented –
1) By Treatment Type: Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Surgical Oncology, Other Treatment Types
2) By Patient Profile: Adults, Pediatrics, Geriatrics
3) By Booking Channel: Direct, Online Platforms, Medical Tourism Agencies
4) By Service Provider: Hospitals, Specialty Clinics, Cancer Centers, Other Services
Subsegments:
1) By Chemotherapy: Adjuvant Chemotherapy, Neoadjuvant Chemotherapy, Palliative Chemotherapy, Combination Chemotherapy
2) By Immunotherapy: Immune Checkpoint Inhibitor Therapy, Monoclonal Antibody Therapy, Cancer Vaccine Therapy, Adoptive Cell Transfer Therapy
3) By Radiation Therapy: External Beam Radiation Therapy, Intensity Modulated Radiation Therapy, Image Guided Radiation Therapy, Brachytherapy
4) By Targeted Therapy: Small Molecule Targeted Therapy, Monoclonal Antibody Targeted Therapy, Angiogenesis Inhibitor Therapy, Hormone Targeted Therapy
5) By Surgical Oncology: Minimally Invasive Surgery, Robotic Assisted Surgery, Open Cancer Surgery, Cytoreductive Surgery
6) By Other Treatment Types: Hormone Therapy, Stem Cell Transplantation, Hyperthermia Therapy, Photodynamic Therapy
Oncology Treatment Tourism Market Transformation Trends: What Innovations Are Driving Change?
Leading companies within the oncology treatment tourism market are concentrating on developing sophisticated solutions, particularly advanced oncology therapeutics, to improve the accuracy of treatment and clinical results for individuals with late-stage cancer. Advanced oncology therapeutics refers to a category of innovative medical interventions designed to target cancer at the molecular, cellular, or genetic level. For instance, in September 2025, Booking Health, a Germany-based medical travel facilitator, expanded its services to enhance international access to advanced stage 4 cancer treatments, including immunotherapy, CAR T-cell therapy, and theranostics. The platform offers extensive coordination for patients, encompassing second opinions, personalized treatment plans, travel logistics, and follow-up care. By connecting patients with highly certified German hospitals such as LMU Klinikum, these services facilitate access to cutting-edge oncology options like HIPEC, PIPAC, and radioembolization (Y-90), which are intended to boost survival outcomes, refine treatment precision, and support patient-centered cancer care.
Oncology Treatment Tourism Market Key Participants And Competitive Landscape
Major companies operating in the oncology treatment tourism market are Mayo Clinic, Memorial Sloan Kettering Cancer Center, Cleveland Clinic, Johns Hopkins Medicine, Apollo Hospitals, Charité-Universitätsmedizin Berlin, Sheba Medical Center, Dana-Farber Cancer Institute, The Royal Marsden Hospital, Seoul National University Hospital, Clínica Universidad de Navarra, Karolinska University Hospital, Institut Curie, Istituto Nazionale dei Tumori, Asan Medical Center, Netherlands Cancer Institute, The Christie NHS Foundation Trust, Cancer Institute Hospital of JFCR, HCG Cancer Centre, Princess Margaret Cancer Centre, MD Anderson Cancer Center.
View The Full Oncology Treatment Tourism Market Report:
Oncology Treatment Tourism Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the oncology treatment tourism market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology treatment tourism market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model